BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3615349)

  • 1. Regional differences in the changes in rat brain GABA concentrations post mortem and following inhibition of the synthesis and metabolism.
    Andén NE; Lindgren S; Magnusson A
    Pharmacol Toxicol; 1987 May; 60(5):393-6. PubMed ID: 3615349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the normal nerve impulse flow on the synthesis and utilization of GABA in the rat substantia nigra.
    Lindgren S; Andén NE
    J Neural Transm; 1985; 61(1-2):21-34. PubMed ID: 3981161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the use of enzyme inhibitors to study the synthesis and utilization of brain GABA.
    Lindgren S; Andén NE
    Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):41-9. PubMed ID: 6087618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):33-46. PubMed ID: 3035084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of KCl-induced depolarization on the GABA concentration in the corpus striatum and in the substantia nigra.
    Lindgren S
    J Neural Transm; 1986; 66(3-4):161-70. PubMed ID: 3783143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
    Hill JM
    Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus.
    Wasterlain CG; Baxter CF; Baldwin RA
    Neurochem Res; 1993 Apr; 18(4):527-32. PubMed ID: 8474571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ethanol on gamma-vinyl GABA-induced GABA accumulation in the substantia nigra and on synaptosomal GABA content in six rat brain regions.
    Frye GD; Fincher AS
    Brain Res; 1988 May; 449(1-2):71-9. PubMed ID: 3395859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex difference in the turnover of GABA in the rat substantia nigra.
    Manev H; Pericić D
    J Neural Transm; 1987; 70(3-4):321-8. PubMed ID: 3681288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity uptake of GABA in presumed GABA-ERGIC nerve endings in rat brain.
    Storm-Mathisen J
    Brain Res; 1975 Feb; 84(3):409-27. PubMed ID: 1122379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous gamma-hydroxybutyrate in rat brain areas: postmortem changes and effects of drugs interfering with gamma-aminobutyric acid metabolism.
    Eli M; Cattabeni F
    J Neurochem; 1983 Aug; 41(2):524-30. PubMed ID: 6875551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
    Bolam JP; Smith Y
    Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic elevation of brain GABA by gamma-vinyl GABA treatment does not alter the sensitivity of GABAergic or dopaminergic receptors in rat CNS.
    Gardner CR; Mallorga P; Klein J; Huot-Olivier S; Palfreyman MG
    Psychopharmacology (Berl); 1983; 79(2-3):130-6. PubMed ID: 6302725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo.
    Casu M; Gale K
    Life Sci; 1981 Aug; 29(7):681-8. PubMed ID: 7278507
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
    Löscher W; Hönack D; Bloms-Funke P
    Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.